期刊文献+

青年男女急性心肌梗死的临床特点对比分析 被引量:7

Clinical features analysis of young female and young male acute myocardial infarction patients
下载PDF
导出
摘要 目的:分析青年男女急性心肌梗死(AMI)的临床特点。方法:从危险因素、发病诱因、临床表现、并发症及急性期预后因素等几个方面对比分析年龄≤45岁男、女性的AMI临床特点。结果:青年女性AMI的主要危险因素为高血脂、高血压、糖尿病、心血管病阳性家族史以及合并其他疾病。青年男性AMI的主要危险因素为吸烟、高血脂、高血压、心血管病阳性家族史、糖尿病。46%的青年女性AMI有明确诱因,低于青年男性的82%。结论:青年女性AMI与男性相比主要危险因素明显不同。 Objective:To analyze clinical features of acute myocardial infarction(AMI) among young male and female.Methods:Risk factor,motivation,clinical situation,complication and prognosis of the acute stage were contrasted between young male and female AMI patient who is not more than 45.Results:Risk factors of young female AMI were hyperlipemia,hypertension,diabetes,angiocardiopathy family history or complicating other disease.Smoking,hyperlipemia,hypertension,angiocardiopathy family history and diabetes were the risk factors of young male AMI.46% young female AMI had obviously motivation,less than young male AMI,which was 82%.Conclusion:The major risk factors were different between young female AMI and young male AMI.
作者 张晓波 曲环
出处 《临床医药实践》 2010年第7期491-493,共3页 Proceeding of Clinical Medicine
关键词 青年 急性心肌梗死 危险因素 冠状动脉造影 临床特征 young patient acute myocardial infarction risk factor coronary arteriongraphy clinical features
  • 相关文献

参考文献5

二级参考文献21

  • 1乔树宾,陈在嘉.内皮源性舒缓因子与冠心病[J].心血管病学进展,1993,14(6):356-360. 被引量:14
  • 2北京地区冠心病协作组.北京地区急性心肌梗塞1972-1983年住院病例的临床概况及发病趋势[J].中华心血管病杂志,1985,13:162-165.
  • 3张心忠 张心华.青年心肌梗塞30例临床分析[J].临床内科杂志,1989,6:37-37.
  • 4[1]The TIMI Ⅲ B investgators. Effects of tissue plasminogen activator and comparison of early invasive and conservative strategies in unstable angina and Non-Q-Wave myocardial infarction: Results of the TIMI ⅢB Trial[J]. Circulation, 1994,89:1545-1556.
  • 5[2]The global use of strategies to open occluded coronary arteries (GUSTO) Ⅱ. A investigators: Randomized trial of intravenous heparin Versus recombinant hirudin for acute coronary syndromes[J]. N Engl J med, 1996, 335:775-782.
  • 6[3]Fragmin during instability in coronary artery disease (FRISC) study group. Low molecular weight heparin during instability in coronary artery disease[J]. Lancet, 1996,347:561-567.
  • 7[4]Mizunok, Satumorak, Miyamoto HE, et al. Angioscopic evaluation of coronary artery thrombi in acute coronary syndromes[J]. N Engl J Med, 1992,326:387-391.
  • 8[5]Drieger D, Dawes J. Long term persistence of biological activity follawing administration of Enoxaparin sodium (clexane) is due to sequestration of antithrombin-Blinding low molecular weight fragments-comparison with unfractionated heparin[J]. Thromb Haemost, 1996,75:740-746.
  • 9[6]Tcheng JE, Harrington RA, Marchant KK, et al. Multicenter, randomized, doublebind, placebo-controlled triall of the platelet integrin glycoprotein Ⅱb/Ⅲa blocker integrelin in elective coronary intervention[J]. Circulation, 1995,91:2151-2157.
  • 10[7]Lassen MR, Borris LC, Anderson BS, et al. Efficacy and safety of prolonger thromboprophylaxis with a low molecular weight heparin after total hip arthroplasly[J]. Thrombosis Research, 1998,89:281-287.

共引文献113

同被引文献31

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部